文献速递银屑病与炎症性皮肤病

HLA-C*06:02转基因小鼠用于银屑病模型免疫肽组分析

A transgenic mouse allows characterization of the HLA-C∗06:02 immunopeptidome in a model of psoriasis.
PubMed 文献 · J Invest Dermatol · 2025-12-24

本研究对HLA-C*06:02阳性角质形成细胞和黑素细胞系进行深度免疫肽组分析,并构建HLA-C*06:02转基因小鼠结合咪喹莫特银屑病模型,鉴定出20,812个高置信度HLA-C结合肽配体,为银屑病抗原特异性治疗提供数据基础。

要点

  • HLA-C*06:02是银屑病主要遗传风险决定因素,其呈递肽抗原激活CD8+ T细胞和NK细胞。
  • 研究鉴定20,812个高置信度HLA-C结合肽配体,源自HLA-C*06:02及高度相似的HLA-C*07:01/02免疫肽组。
  • 转基因小鼠结合咪喹莫特模型可评估银屑病样皮肤中HLA-C*06:02的离体免疫肽组。

核心结论

  • 研究提供了全面的HLA-C体外免疫肽组数据集和银屑病相关肽抗原的HLA-C*06:02离体数据集,可能有助于开发新型抗原特异性治愈性疗法。

研究设计与样本

  • 对HLA-C*06:02阳性且HLA-C*07:01或HLA-C*07:02阳性的角质形成细胞和黑素细胞系进行深度免疫肽组分析。
  • 引入HLA-C*06:02转基因小鼠,结合咪喹莫特银屑病模型,评估银屑病样皮肤中HLA-C*06:02的离体免疫肽组。

主要发现

  • 共鉴定20,812个高置信度HLA-C结合肽配体,源自HLA-C*06:02及高度相似的HLA-C*07:01/02免疫肽组。

临床怎么用

  • 研究数据可能为银屑病抗原特异性、治愈性治疗方法的开发提供信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Psoriasis vulgaris is a T-cell-mediated autoimmune skin condition affecting around 1 in 50 people worldwide. Although advanced immunomodulatory therapeutic options have become available in recent years, ongoing disease suppression is still required, with no curative treatment available to date. The HLA class I allele HLA-C∗06:02 is the main genetic risk determinant of psoriasis. HLA-C molecules present peptide antigens to CD8+ T cells and NK cells that in turn elicit and perpetuate the immune response, yet little is known about the ligands presented by HLA-C∗06:02. To gain an understanding of which HLA-C∗06:02-restricted peptides are presented by epidermal cell populations and might be initiators of the autoimmune response in psoriasis, we have conducted an in depth immunopeptidomic analysis of keratinocyte and melanocyte cell lines positive for HLA-C∗06:02 and either HLA-C∗07:01 or HLA-C∗07:02. Furthermore, we introduce an HLA-C∗06:02-transgenic mouse, which, in conjunction with the imiquimod model of psoriasis, allowed us to assess the ex vivo immunopeptidome of HLA-C∗06:02 in psoriasiform skin. Overall, we identified 20,812 high-confidence HLA-C-bound peptide ligands derived from HLA-C∗06:02 and highly similar HLA-C∗07:01/02 immunopeptidomes. Thus, we present a comprehensive HLA-C in vitro immunopeptidomic dataset and an HLA-C∗06:02 ex vivo dataset of psoriasis-relevant peptide antigens that may inform the development of novel antigen-specific, curative therapeutic approaches in psoriasis.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Braun A, Mobbs JI, Chung S, et al. A transgenic mouse allows characterization of the HLA-C∗06:02 immunopeptidome in a model of psoriasis. J Invest Dermatol. 2025. PMID: 41453599. doi:10.1016/j.jid.2025.12.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。